4 news items
Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities
KA
15 May 24
beliefs, expectations and assumptions regarding the future of Kineta's business, future plans and strategies, clinical results and other future conditions
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
ACB
ACRV
AMD
9 Apr 24
confidence in its strategy and highlighted alignment with shareholders through equity ownership in the company.
MediaCo Holding Inc
Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
KA
8 Apr 24
and strategies, clinical results and other future conditions. New risks and uncertainties may emerge from time to time, and it is not possible to predict
Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update
KA
21 Mar 24
beliefs, expectations and assumptions regarding the future of Kineta's business, future plans and strategies, clinical results and other future
- Prev
- 1
- Next